Axonics, Inc. (NASDAQ: AXNX) reported Q2 EPS of ($0.59), $0.10 worse than the analyst estimate of ($0.49). Revenue for the quarter came in at $45.9 million versus the consensus estimate of $39.82 million.

Fiscal year 2021 revenue guidance increased to a range of $186 million to $188 million

For earnings history and earnings-related data on Axonics, Inc. (AXNX) click here.